SAFETY OF TIOTROPIUM RESPIMAT® ADD-ON THERAPY IN PATIENTS AGED 6-17 YEARS WITH SYMPTOMATIC ASTHMA

被引：0
|
作者：
Vogelberg, C. [1 ]
Szefler, S. J. [2 ,3 ]
Hamelmann, E. [4 ,5 ]
Boner, A. [6 ]
Moroni-Zentgraf, P. [7 ]
Engel, M. [7 ]
El Azzi, G. [7 ]
Finnigan, H. [8 ]
Vandewalker, M. [9 ]
机构：
[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[2] Childrens Hosp Colorado, Dept Paediat, Aurora, CO USA
[3] Univ Colorado Denver, Sch Med, Aurora, CO USA
[4] Evangel Krankenhaus Bielefeld, Bochum, Germany
[5] Ruhr Univ, Allergy Ctr, Bochum, Germany
[6] Univ Verona, Dept Paediat, Verona, Italy
[7] Boehringer Ingelheim Pharma GmbH & Co KG, TA Resp Dis, Ingelheim, Germany
[8] Boehringer Ingelheim Ltd, Biostat & Data Sci, Bracknell, Berks, England
[9] Ozarks Inc, Clin Res, Columbia, MO USA
来源：
THORAX | 2016年 / 71卷
关键词：
INHALED CORTICOSTEROIDS;
D O I：
10.1136/thoraxjnl-2016-209333.298
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P155
引用
收藏
页码：A167 / A167
页数：1
相关论文
共 7 条
  • [1] Safety of tiotropium Respimat® in black or African-American patients with symptomatic asthma
    Graham, LeRoy M.
    Kerstjens, Huib A. M.
    Vogelberg, Christian
    Hamelmann, Eckard
    Szefler, Stanley J.
    Pisternick-Ruf, Wendelgard
    Engel, Michael
    El Azzi, Georges
    Unseld, Anna
    Foggs, Michael B.
    RESPIRATORY MEDICINE, 2019, 155 : 58 - 60
  • [2] A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma
    Szefler, Stanley J.
    Murphy, Kevin
    Harper, Thomas, III
    Boner, Attilio
    Laki, Istvan
    Engel, Michael
    El Azzi, Georges
    Moroni-Zentgraf, Petra
    Finnigan, Helen
    Hamelmann, Eckard
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (05) : 1277 - 1287
  • [3] Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients
    Vogelberg, Christian
    Szefler, Stanley J.
    Vrijlandt, Elianne J. L. E.
    Boner, Attilio L.
    Engel, Michael
    El Azzi, Georges
    Vulcu, Sebastian Dan
    Moroni-Zentgraf, Petra M.
    Eickmeier, Olaf
    Hamelmann, Eckard H.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (06)
  • [4] Efficacy and safety of add-on tiotropium in the management of uncontrolled asthma: a patient case series
    Mosnaim, Giselle
    Bizik, Brian K.
    Wilson, Christy
    Bensch, Gregory
    JOURNAL OF ASTHMA, 2022, 59 (06) : 1231 - 1236
  • [5] Tiotropium add-on therapy in adolescents with moderate asthma: A 1-year randomized controlled trial
    Hamelmann, Eckard
    Bateman, Eric D.
    Vogelberg, Christian
    Szefler, Stanley J.
    Vandewalker, Mark
    Moroni-Zentgraf, Petra
    Avis, Mandy
    Unseld, Anna
    Engel, Michael
    Boner, Attilio L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (02) : 441 - +
  • [6] Add-on Tiotropium in Chinese Patients With Moderate Asthma: A Pooled Subgroup Analysis of MezzoTinA-Asthma 1 and 2
    Lin, Jiangtao
    Wan, Huanying
    Kang, Jian
    Ma, Qianli
    Chen, Ping
    Jin, Meiling
    Wang, Haoyan
    Liu, Shuang
    Hao, Qinglin
    Lin, Yong
    Su, Lin
    Hu, Na
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (04) : 519 - 528
  • [7] Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older
    Raphael, Gordon
    Yiu, Gloria
    Sakov, Anat
    Liu, Siyu
    Caracta, Cynthia
    JOURNAL OF ASTHMA, 2018, 55 (06) : 640 - 650
1